25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

AIM ImmunoTech Inc
Buy, Hold or Sell?

Let's analyze AIM ImmunoTech Inc together

I guess you are interested in AIM ImmunoTech Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of AIM ImmunoTech Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about AIM ImmunoTech Inc

I send you an email if I find something interesting about AIM ImmunoTech Inc.

1. Quick Overview

1.1. Quick analysis of AIM ImmunoTech Inc (30 sec.)










1.2. What can you expect buying and holding a share of AIM ImmunoTech Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.05
Expected worth in 1 year
$-0.16
How sure are you?
13.0%

+ What do you gain per year?

Total Gains per Share
$-0.21
Return On Investment
-108.4%

For what price can you sell your share?

Current Price per Share
$0.19
Expected price per share
$0.1628 - $0.2401
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of AIM ImmunoTech Inc (5 min.)




Live pricePrice per Share (EOD)
$0.19
Intrinsic Value Per Share
$-2.18 - $0.74
Total Value Per Share
$-2.14 - $0.79

2.2. Growth of AIM ImmunoTech Inc (5 min.)




Is AIM ImmunoTech Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$2.9m$34m-$25.4m-296.8%

How much money is AIM ImmunoTech Inc making?

Current yearPrevious yearGrowGrow %
Making money-$6.2m-$4.7m-$1.4m-23.8%
Net Profit Margin-13,277.9%-12,136.0%--

How much money comes from the company's main activities?

2.3. Financial Health of AIM ImmunoTech Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#727 / 943

Most Revenue
#697 / 943

Most Profit
#471 / 943

Most Efficient
#874 / 943
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of AIM ImmunoTech Inc?

Welcome investor! AIM ImmunoTech Inc's management wants to use your money to grow the business. In return you get a share of AIM ImmunoTech Inc.

First you should know what it really means to hold a share of AIM ImmunoTech Inc. And how you can make/lose money.

Speculation

The Price per Share of AIM ImmunoTech Inc is $0.19. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of AIM ImmunoTech Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in AIM ImmunoTech Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.05. Based on the TTM, the Book Value Change Per Share is $-0.05 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of AIM ImmunoTech Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.06-30.6%-0.10-51.7%-0.08-42.0%-0.07-38.8%-0.06-30.7%
Usd Book Value Change Per Share-0.05-26.4%-0.05-27.1%-0.04-20.8%0.00-2.4%0.00-2.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.05-26.4%-0.05-27.1%-0.04-20.8%0.00-2.4%0.00-2.5%
Usd Price Per Share0.27-0.40-0.51-1.18-0.84-
Price to Earnings Ratio-1.16--1.38--1.73--4.85--4.20-
Price-to-Total Gains Ratio-5.39-1.38--6.31-25.30-6.61-
Price to Book Ratio5.91-4.21-0.99-2.28-2.87-
Price-to-Total Gains Ratio-5.39-1.38--6.31-25.30-6.61-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.19
Number of shares5263
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.050.00
Usd Total Gains Per Share-0.050.00
Gains per Quarter (5263 shares)-271.11-23.77
Gains per Year (5263 shares)-1,084.44-95.07
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1084-10940-95-105
20-2169-21780-190-200
30-3253-32620-285-295
40-4338-43460-380-390
50-5422-54300-475-485
60-6507-65140-570-580
70-7591-75980-665-675
80-8676-86820-761-770
90-9760-97660-856-865
100-10844-108500-951-960

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.06.00.00.0%0.022.00.00.0%0.038.00.00.0%0.077.00.00.0%37.0186.00.016.6%
Book Value Change Per Share1.03.02.016.7%1.011.010.04.5%6.014.018.015.8%10.030.037.013.0%32.082.0109.014.3%
Dividend per Share0.00.06.00.0%0.00.022.00.0%0.00.038.00.0%0.00.077.00.0%0.00.0223.00.0%
Total Gains per Share1.03.02.016.7%1.011.010.04.5%6.014.018.015.8%10.030.037.013.0%32.082.0109.014.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of AIM ImmunoTech Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.050-0.052+3%-0.039-21%-0.005-91%-0.005-90%
Book Value Per Share--0.0460.135-66%0.535-91%0.632-93%0.431-89%
Current Ratio--0.7501.786-58%16.066-95%30.641-98%16.573-95%
Debt To Asset Ratio--0.7860.577+36%0.088+791%0.166+373%0.235+235%
Debt To Equity Ratio--3.6661.847+99%0.099+3593%0.389+843%0.495+641%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--13726728.00028317861.013-52%59987373.000-77%102741998.265-87%68141291.715-80%
Eps---0.058-0.098+69%-0.080+37%-0.074+27%-0.058+0%
Ev To Ebitda Ratio---0.999-1.541+54%-3.078+208%-7.426+643%-4.793+380%
Ev To Sales Ratio--98.048155.525-37%371.750-74%731.467-87%497.571-80%
Free Cash Flow Per Share---0.051-0.084+63%-0.070+36%-0.058+14%-0.051-1%
Free Cash Flow To Equity Per Share---0.049-0.061+25%-0.068+39%0.003-1603%-0.003-94%
Gross Profit Margin--1.0001.006-1%1.0000%1.0010%1.279-22%
Intrinsic Value_10Y_max--0.742--------
Intrinsic Value_10Y_min---2.181--------
Intrinsic Value_1Y_max---0.163--------
Intrinsic Value_1Y_min---0.271--------
Intrinsic Value_3Y_max---0.309--------
Intrinsic Value_3Y_min---0.774--------
Intrinsic Value_5Y_max---0.237--------
Intrinsic Value_5Y_min---1.229--------
Market Cap12104216.000-42%17200728.00025452830.347-32%32330998.000-47%75470625.002-77%53602068.546-68%
Net Profit Margin---105.714-132.779+26%-121.360+15%-123.890+17%-97.399-8%
Operating Margin---99.943-134.392+34%-133.848+34%-115.838+16%-103.809+4%
Operating Ratio--129.257147.899-13%269.280-52%162.166-20%129.3760%
Pb Ratio4.157-42%5.9074.215+40%0.988+498%2.278+159%2.872+106%
Pe Ratio-0.818+30%-1.162-1.378+19%-1.727+49%-4.850+317%-4.201+261%
Price Per Share0.190-42%0.2700.400-32%0.508-47%1.185-77%0.841-68%
Price To Free Cash Flow Ratio-0.926+30%-1.316-1.324+1%-2.225+69%-7.025+434%-5.151+291%
Price To Total Gains Ratio-3.794+30%-5.3921.382-490%-6.307+17%25.302-121%6.608-182%
Quick Ratio--1.3362.652-50%19.200-93%34.586-96%19.126-93%
Return On Assets---0.272-0.339+25%-0.134-51%-0.131-52%-0.134-51%
Return On Equity---1.271-0.926-27%-0.151-88%-0.234-82%-0.233-82%
Total Gains Per Share---0.050-0.052+3%-0.039-21%-0.005-91%-0.005-90%
Usd Book Value--2912000.0008583666.667-66%34060125.000-91%40272789.474-93%27439389.610-89%
Usd Book Value Change Per Share---0.050-0.052+3%-0.039-21%-0.005-91%-0.005-90%
Usd Book Value Per Share--0.0460.135-66%0.535-91%0.632-93%0.431-89%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--13726728.00028317861.013-52%59987373.000-77%102741998.265-87%68141291.715-80%
Usd Eps---0.058-0.098+69%-0.080+37%-0.074+27%-0.058+0%
Usd Free Cash Flow---3268000.000-5341000.000+63%-4433875.000+36%-3717263.158+14%-3232805.195-1%
Usd Free Cash Flow Per Share---0.051-0.084+63%-0.070+36%-0.058+14%-0.051-1%
Usd Free Cash Flow To Equity Per Share---0.049-0.061+25%-0.068+39%0.003-1603%-0.003-94%
Usd Market Cap12104216.000-42%17200728.00025452830.347-32%32330998.000-47%75470625.002-77%53602068.546-68%
Usd Price Per Share0.190-42%0.2700.400-32%0.508-47%1.185-77%0.841-68%
Usd Profit---3700000.000-6260333.333+69%-4771125.000+29%-4562736.842+23%-3639493.506-2%
Usd Revenue--35000.00046000.000-24%45125.000-22%40500.000-14%53000.000-34%
Usd Total Gains Per Share---0.050-0.052+3%-0.039-21%-0.005-91%-0.005-90%
 EOD+3 -5MRQTTM+18 -20YOY+14 -235Y+11 -2710Y+6 -32

3.3 Fundamental Score

Let's check the fundamental score of AIM ImmunoTech Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.818
Price to Book Ratio (EOD)Between0-14.157
Net Profit Margin (MRQ)Greater than0-105.714
Operating Margin (MRQ)Greater than0-99.943
Quick Ratio (MRQ)Greater than11.336
Current Ratio (MRQ)Greater than10.750
Debt to Asset Ratio (MRQ)Less than10.786
Debt to Equity Ratio (MRQ)Less than13.666
Return on Equity (MRQ)Greater than0.15-1.271
Return on Assets (MRQ)Greater than0.05-0.272
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of AIM ImmunoTech Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.497
Ma 20Greater thanMa 500.211
Ma 50Greater thanMa 1000.233
Ma 100Greater thanMa 2000.269
OpenGreater thanClose0.189
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About AIM ImmunoTech Inc

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat human papilloma viruses, and genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with Amarex Clinical Research LLC; University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente; Jubilant HollisterStier; Sterling Pharma Solutions; Erasmus University Medical Center Rotterdam; Azenova, LLC; and Alcami Corporation. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.

Fundamental data was last updated by Penke on 2024-12-13 11:27:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit AIM ImmunoTech Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare AIM ImmunoTech Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -10,571.4% means that $-105.71 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of AIM ImmunoTech Inc:

  • The MRQ is -10,571.4%. The company is making a huge loss. -2
  • The TTM is -13,277.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-10,571.4%TTM-13,277.9%+2,706.5%
TTM-13,277.9%YOY-12,136.0%-1,141.9%
TTM-13,277.9%5Y-12,389.0%-888.9%
5Y-12,389.0%10Y-9,739.9%-2,649.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-10,571.4%-109.0%-10,462.4%
TTM-13,277.9%-220.8%-13,057.1%
YOY-12,136.0%-207.5%-11,928.5%
5Y-12,389.0%-350.0%-12,039.0%
10Y-9,739.9%-473.2%-9,266.7%
4.3.1.2. Return on Assets

Shows how efficient AIM ImmunoTech Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare AIM ImmunoTech Inc to the Biotechnology industry mean.
  • -27.2% Return on Assets means that AIM ImmunoTech Inc generated $-0.27 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of AIM ImmunoTech Inc:

  • The MRQ is -27.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -33.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-27.2%TTM-33.9%+6.7%
TTM-33.9%YOY-13.4%-20.5%
TTM-33.9%5Y-13.1%-20.8%
5Y-13.1%10Y-13.4%+0.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.2%-11.6%-15.6%
TTM-33.9%-11.9%-22.0%
YOY-13.4%-11.2%-2.2%
5Y-13.1%-12.6%-0.5%
10Y-13.4%-14.2%+0.8%
4.3.1.3. Return on Equity

Shows how efficient AIM ImmunoTech Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare AIM ImmunoTech Inc to the Biotechnology industry mean.
  • -127.1% Return on Equity means AIM ImmunoTech Inc generated $-1.27 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of AIM ImmunoTech Inc:

  • The MRQ is -127.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -92.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-127.1%TTM-92.6%-34.4%
TTM-92.6%YOY-15.1%-77.6%
TTM-92.6%5Y-23.4%-69.2%
5Y-23.4%10Y-23.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-127.1%-14.3%-112.8%
TTM-92.6%-15.9%-76.7%
YOY-15.1%-14.7%-0.4%
5Y-23.4%-18.5%-4.9%
10Y-23.3%-19.2%-4.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of AIM ImmunoTech Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient AIM ImmunoTech Inc is operating .

  • Measures how much profit AIM ImmunoTech Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare AIM ImmunoTech Inc to the Biotechnology industry mean.
  • An Operating Margin of -9,994.3% means the company generated $-99.94  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of AIM ImmunoTech Inc:

  • The MRQ is -9,994.3%. The company is operating very inefficient. -2
  • The TTM is -13,439.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-9,994.3%TTM-13,439.2%+3,444.9%
TTM-13,439.2%YOY-13,384.8%-54.5%
TTM-13,439.2%5Y-11,583.8%-1,855.4%
5Y-11,583.8%10Y-10,380.9%-1,203.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9,994.3%-208.0%-9,786.3%
TTM-13,439.2%-316.8%-13,122.4%
YOY-13,384.8%-216.9%-13,167.9%
5Y-11,583.8%-379.8%-11,204.0%
10Y-10,380.9%-480.9%-9,900.0%
4.3.2.2. Operating Ratio

Measures how efficient AIM ImmunoTech Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 129.26 means that the operating costs are $129.26 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of AIM ImmunoTech Inc:

  • The MRQ is 129.257. The company is inefficient in keeping operating costs low. -1
  • The TTM is 147.899. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ129.257TTM147.899-18.642
TTM147.899YOY269.280-121.381
TTM147.8995Y162.166-14.267
5Y162.16610Y129.376+32.790
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ129.2572.284+126.973
TTM147.8993.244+144.655
YOY269.2803.262+266.018
5Y162.1664.764+157.402
10Y129.3766.437+122.939
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of AIM ImmunoTech Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if AIM ImmunoTech Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.75 means the company has $0.75 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of AIM ImmunoTech Inc:

  • The MRQ is 0.750. The company is unable to pay all its short-term debts. -2
  • The TTM is 1.786. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ0.750TTM1.786-1.036
TTM1.786YOY16.066-14.280
TTM1.7865Y30.641-28.855
5Y30.64110Y16.573+14.068
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7503.569-2.819
TTM1.7863.865-2.079
YOY16.0664.644+11.422
5Y30.6415.968+24.673
10Y16.5736.209+10.364
4.4.3.2. Quick Ratio

Measures if AIM ImmunoTech Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare AIM ImmunoTech Inc to the Biotechnology industry mean.
  • A Quick Ratio of 1.34 means the company can pay off $1.34 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of AIM ImmunoTech Inc:

  • The MRQ is 1.336. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 2.652. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.336TTM2.652-1.316
TTM2.652YOY19.200-16.548
TTM2.6525Y34.586-31.935
5Y34.58610Y19.126+15.460
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3363.086-1.750
TTM2.6523.384-0.732
YOY19.2004.304+14.896
5Y34.5865.954+28.632
10Y19.1266.436+12.690
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of AIM ImmunoTech Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of AIM ImmunoTech Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare AIM ImmunoTech Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.79 means that AIM ImmunoTech Inc assets are financed with 78.6% credit (debt) and the remaining percentage (100% - 78.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of AIM ImmunoTech Inc:

  • The MRQ is 0.786. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.577. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.786TTM0.577+0.209
TTM0.577YOY0.088+0.489
TTM0.5775Y0.166+0.411
5Y0.16610Y0.235-0.069
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7860.346+0.440
TTM0.5770.346+0.231
YOY0.0880.311-0.223
5Y0.1660.365-0.199
10Y0.2350.383-0.148
4.5.4.2. Debt to Equity Ratio

Measures if AIM ImmunoTech Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare AIM ImmunoTech Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 366.6% means that company has $3.67 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of AIM ImmunoTech Inc:

  • The MRQ is 3.666. The company is unable to pay all its debts with equity. -1
  • The TTM is 1.847. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ3.666TTM1.847+1.819
TTM1.847YOY0.099+1.748
TTM1.8475Y0.389+1.458
5Y0.38910Y0.495-0.106
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6660.393+3.273
TTM1.8470.432+1.415
YOY0.0990.387-0.288
5Y0.3890.453-0.064
10Y0.4950.498-0.003
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings AIM ImmunoTech Inc generates.

  • Above 15 is considered overpriced but always compare AIM ImmunoTech Inc to the Biotechnology industry mean.
  • A PE ratio of -1.16 means the investor is paying $-1.16 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of AIM ImmunoTech Inc:

  • The EOD is -0.818. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.162. Based on the earnings, the company is expensive. -2
  • The TTM is -1.378. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.818MRQ-1.162+0.344
MRQ-1.162TTM-1.378+0.215
TTM-1.378YOY-1.727+0.349
TTM-1.3785Y-4.850+3.473
5Y-4.85010Y-4.201-0.649
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.818-2.088+1.270
MRQ-1.162-2.565+1.403
TTM-1.378-3.166+1.788
YOY-1.727-3.244+1.517
5Y-4.850-6.006+1.156
10Y-4.201-6.718+2.517
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of AIM ImmunoTech Inc:

  • The EOD is -0.926. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.316. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.324. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.926MRQ-1.316+0.390
MRQ-1.316TTM-1.324+0.008
TTM-1.324YOY-2.225+0.901
TTM-1.3245Y-7.025+5.701
5Y-7.02510Y-5.151-1.873
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.926-2.720+1.794
MRQ-1.316-3.295+1.979
TTM-1.324-3.674+2.350
YOY-2.225-4.477+2.252
5Y-7.025-8.054+1.029
10Y-5.151-9.225+4.074
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of AIM ImmunoTech Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 5.91 means the investor is paying $5.91 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of AIM ImmunoTech Inc:

  • The EOD is 4.157. Based on the equity, the company is fair priced.
  • The MRQ is 5.907. Based on the equity, the company is overpriced. -1
  • The TTM is 4.215. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD4.157MRQ5.907-1.750
MRQ5.907TTM4.215+1.692
TTM4.215YOY0.988+3.226
TTM4.2155Y2.278+1.937
5Y2.27810Y2.872-0.594
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.1571.866+2.291
MRQ5.9072.055+3.852
TTM4.2152.392+1.823
YOY0.9882.453-1.465
5Y2.2783.716-1.438
10Y2.8724.373-1.501
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of AIM ImmunoTech Inc.

4.8.3. Insider Transactions

Insiders are holding 8.571% of the shares of AIM ImmunoTech Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-01-03Stewart AppelrouthBUY806460.31217063
2023-01-03Thomas K EquelsBUY1612910.31543995
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-01-312024-03-312024-04-302024-06-302024-09-30
Net Working Capital  1,43001,43001,430891,519-4,049-2,530



5.2. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets13,588
Total Liabilities10,676
Total Stockholder Equity2,912
 As reported
Total Liabilities 10,676
Total Stockholder Equity+ 2,912
Total Assets = 13,588

Assets

Total Assets13,588
Total Current Assets7,570
Long-term Assets6,018
Total Current Assets
Cash And Cash Equivalents 915
Short-term Investments 6,287
Other Current Assets 368
Total Current Assets  (as reported)7,570
Total Current Assets  (calculated)7,570
+/-0
Long-term Assets
Property Plant Equipment 770
Intangible Assets 2,532
Long-term Assets Other 2,716
Long-term Assets  (as reported)6,018
Long-term Assets  (calculated)6,018
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities10,100
Long-term Liabilities576
Total Stockholder Equity2,912
Total Current Liabilities
Short-term Debt 2,825
Short Long Term Debt 2,593
Accounts payable 6,264
Other Current Liabilities 1,011
Total Current Liabilities  (as reported)10,100
Total Current Liabilities  (calculated)12,693
+/- 2,593
Long-term Liabilities
Capital Lease Obligations 669
Long-term Liabilities  (as reported)576
Long-term Liabilities  (calculated)669
+/- 93
Total Stockholder Equity
Common Stock59
Retained Earnings -420,861
Other Stockholders Equity 423,714
Total Stockholder Equity (as reported)2,912
Total Stockholder Equity (calculated)2,912
+/-0
Other
Capital Stock59
Cash and Short Term Investments 7,202
Common Stock Shares Outstanding 57,677
Current Deferred Revenue1
Liabilities and Stockholders Equity 13,588
Net Debt 2,486
Net Invested Capital 5,644
Net Working Capital -2,530
Property Plant and Equipment Gross 2,119
Short Long Term Debt Total 3,401



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-04-302024-03-312024-01-312023-12-312023-10-312023-09-302023-07-312023-06-302023-04-302023-03-312023-01-312022-12-312022-10-312022-09-302022-07-312022-06-302022-04-302022-03-312022-01-312021-12-312021-10-312021-09-302021-07-312021-06-302021-04-302021-03-312021-01-312020-12-312020-10-312020-09-302020-07-312020-06-302020-04-302020-03-312020-01-312019-12-312019-10-312019-09-302019-07-312019-06-302019-04-302019-03-312019-01-312018-10-312018-09-302018-07-312018-06-302018-04-302018-03-312018-01-312017-12-312017-10-312017-09-302017-07-312017-06-302017-04-302017-03-312017-01-312016-12-312016-10-312016-09-302016-07-312016-06-302016-04-302016-03-312016-01-312015-12-312015-10-312015-09-302015-07-312015-06-302015-04-302015-03-312015-01-312014-12-312014-10-312014-09-302014-07-312014-06-302014-04-302014-03-312014-01-312013-12-312013-10-312013-09-302013-07-312013-06-302013-04-302013-03-312013-01-312012-12-312012-10-312012-09-302012-07-312012-06-302012-04-302012-03-312012-01-312011-12-312011-10-312011-09-302011-07-312011-06-302011-04-302011-03-312011-01-312010-12-312010-10-312010-09-302010-07-312010-06-302010-04-302010-03-312010-01-312009-12-312009-10-312009-09-302009-07-312009-06-302009-04-302009-03-312009-01-312008-12-312008-10-312008-09-302008-07-312008-06-302008-04-302008-03-312008-01-312007-12-312007-10-312007-09-302007-07-312007-06-302007-04-302007-03-312007-01-312006-12-312006-10-312006-09-302006-07-312006-06-302006-04-302006-03-312006-01-312005-10-312005-09-302005-07-312005-06-302005-04-302005-03-312005-01-312004-12-312004-10-312004-09-302004-07-312004-06-302004-04-302004-03-312004-01-312003-12-312003-10-312003-09-302003-07-312003-06-302003-04-302003-03-312003-01-312002-10-312002-09-302002-07-312002-06-302002-04-302002-03-312002-01-312001-10-312001-09-302001-07-312001-06-302001-04-302001-03-312001-01-312000-10-312000-09-302000-07-312000-06-302000-04-302000-03-312000-01-311999-12-311999-10-311999-09-301999-07-311999-06-301999-04-301999-03-311999-01-311998-12-311998-10-311998-09-301998-07-311998-06-301998-04-301998-03-311998-01-311997-12-311997-10-311997-09-301997-07-311997-06-301997-04-301997-03-311997-01-311996-12-311996-10-311996-09-301996-07-311996-06-301996-04-301996-03-311996-01-311995-12-311995-10-311995-09-301995-07-311995-06-301995-04-301995-03-311995-01-31
> Total Assets 
0
0
0
0
0
0
12,700
12,700
5,100
5,100
5,100
4,000
4,000
8,300
8,300
7,000
7,000
5,700
5,700
4,500
4,500
3,500
3,500
11,500
11,500
10,200
10,200
9,100
9,100
17,000
17,000
16,300
16,300
13,900
13,900
12,400
12,400
11,100
11,100
14,200
14,200
16,062
16,062
15,277
15,277
13,543
13,543
13,067
10,586
10,586
9,327
9,327
8,112
8,112
12,035
10,709
10,709
8,512
8,512
6,863
6,863
6,040
8,729
8,729
10,243
10,243
11,992
11,992
13,404
13,404
17,053
17,053
18,933
18,933
27,307
27,307
25,172
25,172
22,574
22,574
20,408
20,408
19,466
19,466
24,672
33,051
33,051
30,645
30,645
28,696
28,696
31,431
31,431
34,335
34,335
29,577
29,577
25,957
25,957
23,142
23,142
20,365
20,365
17,497
17,497
14,943
14,943
13,211
13,211
12,392
12,392
48,443
48,443
67,694
67,694
64,994
64,994
60,884
60,884
57,587
57,587
55,876
55,876
51,680
51,680
51,680
51,680
47,604
47,604
45,535
45,535
43,513
43,513
42,733
42,733
41,110
41,110
48,578
48,578
57,699
57,699
51,659
51,659
46,143
46,143
42,878
42,878
31,867
31,867
35,010
35,010
33,549
33,549
30,638
30,638
29,440
29,440
30,791
30,791
29,866
29,866
26,497
26,497
22,804
22,804
21,500
21,500
21,918
21,918
21,576
21,576
18,873
18,873
16,863
16,863
16,108
16,108
14,725
14,725
14,207
14,207
16,260
16,260
15,685
15,685
15,170
15,170
13,845
15,965
15,965
13,808
13,808
22,490
22,490
20,219
20,219
42,407
42,407
50,123
50,123
64,164
64,164
64,584
64,584
74,089
74,089
66,722
66,722
63,080
63,080
57,699
57,699
54,155
54,155
50,884
50,884
46,285
46,285
40,488
40,488
37,462
37,462
33,617
33,617
27,861
27,861
0
19,418
16,189
16,189
15,715
13,588
13,58815,71516,18916,18919,418027,86127,86133,61733,61737,46237,46240,48840,48846,28546,28550,88450,88454,15554,15557,69957,69963,08063,08066,72266,72274,08974,08964,58464,58464,16464,16450,12350,12342,40742,40720,21920,21922,49022,49013,80813,80815,96515,96513,84515,17015,17015,68515,68516,26016,26014,20714,20714,72514,72516,10816,10816,86316,86318,87318,87321,57621,57621,91821,91821,50021,50022,80422,80426,49726,49729,86629,86630,79130,79129,44029,44030,63830,63833,54933,54935,01035,01031,86731,86742,87842,87846,14346,14351,65951,65957,69957,69948,57848,57841,11041,11042,73342,73343,51343,51345,53545,53547,60447,60451,68051,68051,68051,68055,87655,87657,58757,58760,88460,88464,99464,99467,69467,69448,44348,44312,39212,39213,21113,21114,94314,94317,49717,49720,36520,36523,14223,14225,95725,95729,57729,57734,33534,33531,43131,43128,69628,69630,64530,64533,05133,05124,67219,46619,46620,40820,40822,57422,57425,17225,17227,30727,30718,93318,93317,05317,05313,40413,40411,99211,99210,24310,2438,7298,7296,0406,8636,8638,5128,51210,70910,70912,0358,1128,1129,3279,32710,58610,58613,06713,54313,54315,27715,27716,06216,06214,20014,20011,10011,10012,40012,40013,90013,90016,30016,30017,00017,0009,1009,10010,20010,20011,50011,5003,5003,5004,5004,5005,7005,7007,0007,0008,3008,3004,0004,0005,1005,1005,10012,70012,700000000
   > Total Current Assets 
0
0
0
0
0
0
11,400
11,400
3,700
3,700
3,700
2,600
2,600
6,800
6,800
5,400
5,400
4,200
4,200
3,000
3,000
1,900
1,900
10,100
10,100
8,800
8,800
7,700
7,700
15,500
15,500
13,700
13,700
11,200
11,200
9,200
9,200
7,900
7,900
11,000
11,000
12,346
12,346
10,942
10,942
9,456
9,456
9,045
6,717
6,717
5,527
5,527
4,432
4,432
8,806
7,525
7,525
6,074
6,074
4,418
4,418
4,389
6,899
6,899
7,117
7,117
8,056
8,056
8,607
8,607
10,442
10,442
12,457
12,457
21,284
21,284
19,290
19,290
16,789
16,789
14,726
14,726
13,702
13,702
18,283
25,793
25,793
23,093
23,093
20,481
20,481
23,239
23,239
26,197
26,197
22,499
22,499
19,296
19,296
16,599
16,599
14,091
14,091
11,563
11,563
9,006
9,006
7,313
7,313
6,680
6,680
42,785
42,785
62,074
62,074
58,404
58,404
53,992
53,992
36,818
36,818
38,556
38,556
36,674
36,674
36,674
36,674
33,044
33,044
34,219
34,219
31,786
31,786
33,644
33,644
30,487
30,487
36,454
36,454
44,728
44,728
38,581
38,581
32,882
32,882
29,553
29,553
18,552
18,552
21,887
21,887
20,458
20,458
17,666
17,666
16,507
16,507
17,917
17,917
17,061
17,061
13,979
13,979
10,571
10,571
9,538
9,538
10,730
10,730
9,332
9,332
6,941
6,941
5,190
5,190
4,680
4,680
3,735
3,735
3,505
3,505
5,663
5,663
5,285
5,285
4,943
4,943
3,799
5,855
5,855
3,754
3,754
12,621
12,621
10,446
10,446
29,710
29,710
35,165
35,165
39,757
39,757
40,310
40,310
51,219
51,219
41,325
41,325
38,037
38,037
50,213
50,213
50,380
50,380
46,045
46,045
41,150
41,150
36,321
36,321
33,160
33,160
28,869
28,869
22,742
22,742
0
14,556
11,306
11,306
10,361
7,570
7,57010,36111,30611,30614,556022,74222,74228,86928,86933,16033,16036,32136,32141,15041,15046,04546,04550,38050,38050,21350,21338,03738,03741,32541,32551,21951,21940,31040,31039,75739,75735,16535,16529,71029,71010,44610,44612,62112,6213,7543,7545,8555,8553,7994,9434,9435,2855,2855,6635,6633,5053,5053,7353,7354,6804,6805,1905,1906,9416,9419,3329,33210,73010,7309,5389,53810,57110,57113,97913,97917,06117,06117,91717,91716,50716,50717,66617,66620,45820,45821,88721,88718,55218,55229,55329,55332,88232,88238,58138,58144,72844,72836,45436,45430,48730,48733,64433,64431,78631,78634,21934,21933,04433,04436,67436,67436,67436,67438,55638,55636,81836,81853,99253,99258,40458,40462,07462,07442,78542,7856,6806,6807,3137,3139,0069,00611,56311,56314,09114,09116,59916,59919,29619,29622,49922,49926,19726,19723,23923,23920,48120,48123,09323,09325,79325,79318,28313,70213,70214,72614,72616,78916,78919,29019,29021,28421,28412,45712,45710,44210,4428,6078,6078,0568,0567,1177,1176,8996,8994,3894,4184,4186,0746,0747,5257,5258,8064,4324,4325,5275,5276,7176,7179,0459,4569,45610,94210,94212,34612,34611,00011,0007,9007,9009,2009,20011,20011,20013,70013,70015,50015,5007,7007,7008,8008,80010,10010,1001,9001,9003,0003,0004,2004,2005,4005,4006,8006,8002,6002,6003,7003,7003,70011,40011,400000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
11,300
11,300
3,600
3,600
3,600
2,500
2,500
6,600
6,600
5,300
5,300
4,000
4,000
2,800
2,800
1,800
1,800
9,000
9,000
7,700
7,700
6,600
6,600
14,300
14,300
12,000
12,000
10,500
10,500
9,100
9,100
6,800
6,800
6,400
6,400
9,893
9,893
8,250
8,250
6,899
6,899
3,721
2,057
2,057
2,585
2,585
2,859
2,859
3,107
3,473
3,473
3,298
3,298
3,471
3,471
2,256
3,409
3,409
4,659
4,659
5,061
5,061
3,764
3,764
3,249
3,249
4,464
4,464
12,805
12,805
8,813
8,813
6,689
6,689
5,802
5,802
4,966
4,966
3,827
10,519
10,519
2,555
2,555
4,518
4,518
3,646
3,646
4,179
4,179
6,989
6,989
6,564
6,564
11,471
11,471
9,644
9,644
10,142
10,142
7,592
7,592
6,119
6,119
3,621
3,621
40,657
40,657
61,042
61,042
58,072
58,072
50,723
50,723
5,331
5,331
3,044
3,044
2,920
2,920
2,920
2,920
2,080
2,080
4,022
4,022
3,103
3,103
3,650
3,650
2,170
2,170
3,158
3,158
2,212
2,212
1,588
1,588
1,306
1,306
1,598
1,598
803
803
4,105
4,105
2,617
2,617
1,262
1,262
2,156
2,156
2,942
2,942
1,842
1,842
1,161
1,161
2,115
2,115
1,013
1,013
1,538
1,538
4,473
4,473
2,408
2,408
776
776
1,222
1,222
503
503
1,412
1,412
3,957
3,957
3,568
3,568
4,055
4,055
299
2,394
2,394
959
959
9,616
9,616
1,470
1,470
27,590
27,590
33,908
33,908
38,496
38,496
38,501
38,501
48,773
48,773
41,142
41,142
37,349
37,349
32,093
32,093
28,989
28,989
34,452
34,452
29,759
29,759
27,053
27,053
23,395
23,395
21,038
21,038
15,264
15,264
0
5,439
3,295
3,295
3,554
915
9153,5543,2953,2955,439015,26415,26421,03821,03823,39523,39527,05327,05329,75929,75934,45234,45228,98928,98932,09332,09337,34937,34941,14241,14248,77348,77338,50138,50138,49638,49633,90833,90827,59027,5901,4701,4709,6169,6169599592,3942,3942994,0554,0553,5683,5683,9573,9571,4121,4125035031,2221,2227767762,4082,4084,4734,4731,5381,5381,0131,0132,1152,1151,1611,1611,8421,8422,9422,9422,1562,1561,2621,2622,6172,6174,1054,1058038031,5981,5981,3061,3061,5881,5882,2122,2123,1583,1582,1702,1703,6503,6503,1033,1034,0224,0222,0802,0802,9202,9202,9202,9203,0443,0445,3315,33150,72350,72358,07258,07261,04261,04240,65740,6573,6213,6216,1196,1197,5927,59210,14210,1429,6449,64411,47111,4716,5646,5646,9896,9894,1794,1793,6463,6464,5184,5182,5552,55510,51910,5193,8274,9664,9665,8025,8026,6896,6898,8138,81312,80512,8054,4644,4643,2493,2493,7643,7645,0615,0614,6594,6593,4093,4092,2563,4713,4713,2983,2983,4733,4733,1072,8592,8592,5852,5852,0572,0573,7216,8996,8998,2508,2509,8939,8936,4006,4006,8006,8009,1009,10010,50010,50012,00012,00014,30014,3006,6006,6007,7007,7009,0009,0001,8001,8002,8002,8004,0004,0005,3005,3006,6006,6002,5002,5003,6003,6003,60011,30011,300000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,000
1,000
1,000
2,200
2,200
2,236
2,236
2,237
2,237
2,282
2,282
4,657
4,086
4,086
2,395
2,395
1,236
1,236
5,310
2,720
2,720
2,542
2,542
837
837
555
555
555
0
0
0
1,495
1,495
1,495
3,989
3,989
4,969
4,969
6,020
6,020
7,924
7,924
7,718
7,718
6,812
6,812
6,666
6,666
12,377
13,393
13,393
18,963
18,963
14,505
14,505
18,375
18,375
20,421
20,421
14,670
14,670
11,290
11,290
3,944
3,944
2,989
2,989
0
0
0
0
0
1,920
1,920
1,920
1,000
1,000
0
0
0
3,053
3,053
3,053
30,433
30,433
34,202
34,202
32,689
32,689
32,689
32,689
29,530
29,530
28,737
28,737
27,255
27,255
28,540
28,540
26,785
26,785
32,240
32,240
41,741
41,741
36,247
36,247
31,217
31,217
27,623
27,623
17,391
17,391
17,449
17,449
17,595
17,595
16,169
16,169
13,952
13,952
14,063
14,063
13,872
13,872
11,214
11,214
6,795
6,795
6,836
6,836
4,974
4,974
3,536
3,536
3,460
3,460
2,973
2,973
1,989
1,989
1,800
1,800
695
695
682
682
674
674
20
20
1,526
2,486
2,486
1,905
1,905
2,114
2,114
7,308
7,308
499
499
1,093
1,093
1,144
1,144
501
501
1,164
1,164
0
16,135
499
499
16,175
16,175
15,554
15,554
7,320
7,320
6,986
6,986
7,137
7,137
7,454
7,454
7,360
7,360
7,167
7,167
0
7,631
7,647
7,647
6,507
6,287
6,2876,5077,6477,6477,63107,1677,1677,3607,3607,4547,4547,1377,1376,9866,9867,3207,32015,55415,55416,17516,17549949916,13501,1641,1645015011,1441,1441,0931,0934994997,3087,3082,1142,1141,9051,9052,4862,4861,52620206746746826826956951,8001,8001,9891,9892,9732,9733,4603,4603,5363,5364,9744,9746,8366,8366,7956,79511,21411,21413,87213,87214,06314,06313,95213,95216,16916,16917,59517,59517,44917,44917,39117,39127,62327,62331,21731,21736,24736,24741,74141,74132,24032,24026,78526,78528,54028,54027,25527,25528,73728,73729,53029,53032,68932,68932,68932,68934,20234,20230,43330,4333,0533,0533,0530001,0001,0001,9201,9201,920000002,9892,9893,9443,94411,29011,29014,67014,67020,42120,42118,37518,37514,50514,50518,96318,96313,39313,39312,3776,6666,6666,8126,8127,7187,7187,9247,9246,0206,0204,9694,9693,9893,9891,4951,4951,4950005555555558378372,5422,5422,7202,7205,3101,2361,2362,3952,3954,0864,0864,6572,2822,2822,2372,2372,2362,2362,2002,2001,0001,0001,000000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
100
100
100
100
100
100
100
100
100
100
100
2,300
2,300
95
95
88
88
83
83
60
36
36
11
11
13
13
8
562
562
10
10
12
12
1,507
1,519
1,519
52
52
141
141
282
282
280
280
156
156
98
98
139
139
139
139
72
72
68
68
96
62
62
189
189
279
279
93
93
559
559
83
83
132
132
77
77
51
51
3
3
165
165
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,793
0
6,077
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,142
1,142
0
0
0
41
41
41
98
98
42
42
24
24
29
29
35
35
28
28
1,094
101
101
76
76
62
62
820
820
822
822
46
46
26
26
1,124
1,124
1,124
1,124
28
28
28
28
1,641
1,641
1,641
1,641
0
0
0
1,676
1,676
1,676
1,763
1,763
33
33
48
48
0
1,184
1,184
0
0
0
0001,1841,1840484833331,7631,7631,6761,6761,6760001,6411,6411,6411,641282828281,1241,1241,1241,12426264646822822820820626276761011011,0942828353529292424424298984141410001,1421,1420000000000000000000000000000000000006,07703,79300000000000000000000016516533515177771321328383559559939327927918918962629668687272139139139139989815615628028028228214114152521,5191,5191,507121210105625628131311113636608383888895952,3002,30010010010010010010010010010010010010010000000000000000000000000000
       Other Current Assets 
0
0
0
0
0
0
100
100
100
100
100
100
100
200
200
100
100
200
200
200
200
100
100
1,100
1,100
1,100
1,100
1,000
1,000
1,100
1,100
1,600
1,600
600
600
0
0
0
100
100
100
122
122
368
368
192
192
607
538
538
536
536
324
324
381
770
770
224
224
98
98
71
142
142
239
239
309
309
170
170
139
139
245
245
78
78
266
266
304
304
225
225
168
168
216
189
189
116
116
87
87
168
168
195
195
159
159
610
610
450
450
450
450
384
384
385
385
330
330
275
275
264
264
168
168
332
332
216
216
120
120
235
235
278
278
278
278
468
468
371
371
531
531
346
346
425
425
257
257
322
322
293
293
359
359
332
332
358
358
333
333
246
246
235
235
399
399
432
432
338
338
278
278
335
335
363
363
1,750
1,750
1,323
1,323
1,073
1,073
1,400
1,400
1,371
1,371
1,390
1,390
1,374
1,374
995
995
1,008
1,008
840
840
880
874
874
814
814
829
829
848
848
799
799
118
118
91
91
184
184
158
158
155
155
161
161
304
304
296
296
373
373
805
805
455
455
548
548
438
438
263
263
0
302
364
364
300
368
368300364364302026326343843854854845545580580537337329629630430416116115515515815818418491911181187997998488488298298148148748748808408401,0081,0089959951,3741,3741,3901,3901,3711,3711,4001,4001,0731,0731,3231,3231,7501,750363363335335278278338338432432399399235235246246333333358358332332359359293293322322257257425425346346531531371371468468278278278278235235120120216216332332168168264264275275330330385385384384450450450450610610159159195195168168878711611618918921616816822522530430426626678782452451391391701703093092392391421427198982242247707703813243245365365385386071921923683681221221001001000006006001,6001,6001,1001,1001,0001,0001,1001,1001,1001,100100100200200200200100100200200100100100100100100100000000
   > Long-term Assets 
0
0
0
0
0
0
1,300
1,300
1,400
1,400
1,400
1,400
1,400
1,500
1,500
1,600
1,600
1,500
1,500
1,500
1,500
1,600
1,600
1,400
1,400
1,400
1,400
1,400
1,400
1,500
1,500
2,600
2,600
2,700
2,700
3,200
3,200
3,200
3,200
3,200
3,200
3,716
3,716
4,335
4,335
4,088
4,088
4,022
3,869
3,869
3,800
3,800
3,680
3,680
3,229
3,184
3,184
2,438
2,438
2,445
2,445
1,651
1,830
1,830
3,126
3,126
3,936
3,936
4,797
4,797
6,611
6,611
6,476
6,476
6,023
6,023
5,882
5,882
5,785
5,785
5,682
5,682
5,764
5,764
6,389
7,258
7,258
7,552
7,552
8,215
8,215
8,192
8,192
8,138
8,138
7,078
7,078
6,661
6,661
6,543
6,543
6,274
6,274
5,934
5,934
5,937
5,937
5,898
5,898
5,712
5,712
5,658
5,658
5,620
5,620
6,590
6,590
6,892
6,892
20,769
20,769
17,320
17,320
15,006
15,006
15,006
15,006
14,560
14,560
11,316
11,316
11,727
11,727
9,089
9,089
10,623
10,623
12,124
12,124
12,971
12,971
13,078
13,078
13,261
13,261
13,325
13,325
13,315
13,315
13,123
13,123
13,091
13,091
12,972
12,972
12,933
12,933
12,874
12,874
12,805
12,805
12,518
12,518
12,233
12,233
11,962
11,962
11,188
11,188
12,244
12,244
11,932
11,932
11,673
11,673
11,428
11,428
10,990
10,990
10,702
10,702
10,597
10,597
10,400
10,400
10,227
10,227
10,046
10,110
10,110
10,054
10,054
9,869
9,869
9,773
9,773
12,697
12,697
14,958
14,958
24,407
24,407
24,274
24,274
22,870
22,870
25,397
25,397
25,043
25,043
7,486
7,486
3,775
3,775
4,839
4,839
5,135
5,135
4,167
4,167
4,302
4,302
4,748
4,748
5,119
5,119
0
4,862
4,883
4,883
5,354
6,018
6,0185,3544,8834,8834,86205,1195,1194,7484,7484,3024,3024,1674,1675,1355,1354,8394,8393,7753,7757,4867,48625,04325,04325,39725,39722,87022,87024,27424,27424,40724,40714,95814,95812,69712,6979,7739,7739,8699,86910,05410,05410,11010,11010,04610,22710,22710,40010,40010,59710,59710,70210,70210,99010,99011,42811,42811,67311,67311,93211,93212,24412,24411,18811,18811,96211,96212,23312,23312,51812,51812,80512,80512,87412,87412,93312,93312,97212,97213,09113,09113,12313,12313,31513,31513,32513,32513,26113,26113,07813,07812,97112,97112,12412,12410,62310,6239,0899,08911,72711,72711,31611,31614,56014,56015,00615,00615,00615,00617,32017,32020,76920,7696,8926,8926,5906,5905,6205,6205,6585,6585,7125,7125,8985,8985,9375,9375,9345,9346,2746,2746,5436,5436,6616,6617,0787,0788,1388,1388,1928,1928,2158,2157,5527,5527,2587,2586,3895,7645,7645,6825,6825,7855,7855,8825,8826,0236,0236,4766,4766,6116,6114,7974,7973,9363,9363,1263,1261,8301,8301,6512,4452,4452,4382,4383,1843,1843,2293,6803,6803,8003,8003,8693,8694,0224,0884,0884,3354,3353,7163,7163,2003,2003,2003,2003,2003,2002,7002,7002,6002,6001,5001,5001,4001,4001,4001,4001,4001,4001,6001,6001,5001,5001,5001,5001,6001,6001,5001,5001,4001,4001,4001,4001,4001,3001,300000000
       Property Plant Equipment 
0
0
0
0
0
0
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
200
200
200
200
300
300
300
300
300
300
300
300
366
366
390
390
347
347
373
338
338
302
302
274
274
246
222
222
199
199
177
177
155
133
133
131
131
112
112
94
94
3,387
3,387
3,357
3,357
3,327
3,327
3,303
3,303
3,343
3,343
3,325
3,325
3,331
3,331
4,185
5,021
5,021
5,349
5,349
5,319
5,319
5,344
5,344
5,302
5,302
5,568
5,568
5,150
5,150
4,821
4,821
5,063
5,063
4,978
4,978
4,904
4,904
4,877
4,877
4,794
4,794
4,694
4,694
4,651
4,651
4,839
4,839
5,127
5,127
5,080
5,080
5,258
5,258
5,361
5,361
5,361
5,361
5,604
5,604
5,950
5,950
6,760
6,760
8,163
8,163
9,672
9,672
11,112
11,112
5,292
5,292
11,937
11,937
12,056
12,056
12,115
12,115
12,099
12,099
11,997
11,997
12,033
12,033
11,985
11,985
11,938
11,938
11,805
11,805
11,720
11,720
11,501
11,501
11,237
11,237
10,937
10,937
10,057
10,057
9,779
9,779
9,514
9,514
9,257
9,257
9,022
9,022
8,795
8,795
8,586
8,586
8,370
8,370
8,142
8,142
7,976
7,976
7,782
7,739
7,739
7,638
7,638
7,454
7,454
7,268
7,268
7,091
7,091
6,915
6,915
6,817
6,817
6,652
6,652
6,479
6,479
6,302
6,302
6,138
6,138
4,196
4,196
281
281
1,016
1,016
984
984
1,024
1,024
947
947
926
926
863
863
0
824
881
881
809
770
77080988188182408638639269269479471,0241,0249849841,0161,0162812814,1964,1966,1386,1386,3026,3026,4796,4796,6526,6526,8176,8176,9156,9157,0917,0917,2687,2687,4547,4547,6387,6387,7397,7397,7827,9767,9768,1428,1428,3708,3708,5868,5868,7958,7959,0229,0229,2579,2579,5149,5149,7799,77910,05710,05710,93710,93711,23711,23711,50111,50111,72011,72011,80511,80511,93811,93811,98511,98512,03312,03311,99711,99712,09912,09912,11512,11512,05612,05611,93711,9375,2925,29211,11211,1129,6729,6728,1638,1636,7606,7605,9505,9505,6045,6045,3615,3615,3615,3615,2585,2585,0805,0805,1275,1274,8394,8394,6514,6514,6944,6944,7944,7944,8774,8774,9044,9044,9784,9785,0635,0634,8214,8215,1505,1505,5685,5685,3025,3025,3445,3445,3195,3195,3495,3495,0215,0214,1853,3313,3313,3253,3253,3433,3433,3033,3033,3273,3273,3573,3573,3873,3879494112112131131133133155177177199199222222246274274302302338338373347347390390366366300300300300300300300300200200200200100100100100100100100100100100100100100100100100100100100100100100100000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,068
1,068
1,068
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
980
0
366
0
366
0
366
0
366
0
366
0
366
0
366
0
366
0
366
0
366
0
366
0
366
0
366
0
366
0
366
0
366
0
366
0
366
0
366
0
366
0
366
0
366
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000036603660366036603660366036603660366036603660366036603660366036603660366036603660366036609800000000000000000000000000000001,0681,0681,06800000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,012
0
5,308
0
14,836
0
15,376
0
13,664
0
16,135
0
15,811
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000015,811016,135013,664015,376014,83605,30803,012000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
1,200
1,200
1,300
1,300
1,300
1,300
1,300
1,400
1,400
1,500
1,500
1,500
1,500
1,500
1,500
1,600
1,600
1,400
1,400
1,300
1,300
1,300
1,300
1,300
1,300
1,400
1,400
1,400
1,400
1,400
1,400
1,400
1,400
1,400
1,400
1,326
1,326
1,292
1,292
1,229
1,229
1,204
1,110
1,110
1,051
1,051
986
986
1,025
1,025
1,025
1,026
1,026
1,087
1,087
995
978
978
2,154
2,154
1,346
1,346
1,027
1,027
992
992
988
988
918
918
908
908
866
866
805
805
793
793
795
789
789
775
775
875
875
857
857
878
878
885
885
902
902
958
958
926
926
904
904
981
981
969
969
867
867
913
913
918
918
830
830
838
838
836
836
974
974
794
794
794
794
735
735
725
725
863
863
861
861
886
886
947
947
1,034
1,034
1,076
1,076
1,069
1,069
1,074
1,074
1,080
1,080
990
990
924
924
853
853
861
861
935
935
951
951
883
883
862
862
893
893
899
899
919
919
872
872
870
870
860
860
860
860
858
858
858
858
886
886
879
879
912
1,019
1,019
1,062
1,062
1,061
1,061
1,151
1,151
1,240
1,240
1,381
1,381
1,407
1,407
1,498
1,498
1,798
1,798
1,783
1,783
1,845
1,845
1,974
1,974
1,988
1,988
2,012
2,012
2,013
2,013
1,941
1,941
1,898
1,898
2,038
2,038
2,154
2,154
0
2,313
2,314
2,314
2,491
2,532
2,5322,4912,3142,3142,31302,1542,1542,0382,0381,8981,8981,9411,9412,0132,0132,0122,0121,9881,9881,9741,9741,8451,8451,7831,7831,7981,7981,4981,4981,4071,4071,3811,3811,2401,2401,1511,1511,0611,0611,0621,0621,0191,0199128798798868868588588588588608608608608708708728729199198998998938938628628838839519519359358618618538539249249909901,0801,0801,0741,0741,0691,0691,0761,0761,0341,0349479478868868618618638637257257357357947947947949749748368368388388308309189189139138678679699699819819049049269269589589029028858858788788578578758757757757897897957937938058058668669089089189189889889929921,0271,0271,3461,3462,1542,1549789789951,0871,0871,0261,0261,0251,0251,0259869861,0511,0511,1101,1101,2041,2291,2291,2921,2921,3261,3261,4001,4001,4001,4001,4001,4001,4001,4001,4001,4001,3001,3001,3001,3001,3001,3001,4001,4001,6001,6001,5001,5001,5001,5001,5001,5001,4001,4001,3001,3001,3001,3001,3001,2001,200000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
877
0
912
0
958
0
916
818
0
766
0
670
0
621
517
0
435
0
359
0
296
2,018
0
2,011
0
1,951
0
1,931
0
127
0
261
0
238
0
221
0
315
0
386
0
299
0
321
463
0
462
0
439
0
384
0
721
0
720
0
1,900
0
3,228
0
3,826
0
3,956
0
4,070
0
4,269
0
3,060
0
2,147
0
1,552
0
1,501
0
2,685
0
2,623
0
2,643
0
2,583
0
1,901
0
1,852
0
1,802
0
1,753
0
1,276
0
1,227
0
1,177
0
1,154
0
3,060
0
3,062
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,372
0
1,352
1,352
0
1,354
0
1,354
0
1,354
0
1,354
0
1,354
0
1,347
0
16,634
0
17,300
0
1,177
0
1,249
0
1,316
0
1,506
0
1,811
0
2,138
0
1,202
0
1,457
0
1,784
0
2,102
0
0
0
0
0
0
0
0
000000002,10201,78401,45701,20202,13801,81101,50601,31601,24901,177017,300016,63401,34701,35401,35401,35401,35401,35401,3521,35201,372000000000000000000000000000000000000000003,06203,06001,15401,17701,22701,27601,75301,80201,85201,90102,58302,64302,62302,68501,50101,55202,14703,06004,26904,07003,95603,82603,22801,900072007210384043904620463321029903860315022102380261012701,93101,95102,01102,0182960359043505176210670076608189160958091208770000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,198
0
1,198
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000001,19801,19800000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
0
0
0
8,300
8,300
1,400
1,400
1,400
1,600
1,600
1,100
1,100
1,100
1,100
1,000
1,000
900
900
1,400
1,400
800
800
800
800
1,000
1,000
900
900
1,100
1,100
1,700
1,700
2,200
2,200
2,100
2,100
1,500
1,500
1,181
1,181
1,245
1,245
903
903
1,495
1,239
1,239
1,122
1,122
1,249
1,249
1,272
1,350
1,350
818
818
934
934
1,464
4,126
4,126
1,704
1,704
4,632
4,632
4,156
4,156
7,763
7,763
4,887
4,887
4,596
4,596
5,091
5,091
5,299
5,299
5,674
5,674
5,736
5,736
4,835
5,880
5,880
6,772
6,772
7,216
7,216
6,680
6,680
6,911
6,911
2,856
2,856
2,663
2,663
2,187
2,187
2,205
2,205
1,935
1,935
2,162
2,162
1,667
1,667
2,447
2,447
2,535
2,535
1,385
1,385
2,615
2,615
2,488
2,488
1,900
1,900
2,474
2,474
5,733
5,733
5,733
5,733
3,932
3,932
4,962
4,962
5,548
5,548
6,599
6,599
7,575
7,575
11,966
11,966
12,999
12,999
10,279
10,279
9,999
9,999
10,727
10,727
2,569
2,569
3,017
3,017
4,181
4,181
4,273
4,273
4,436
4,436
3,821
3,821
3,102
3,102
3,327
3,327
2,433
2,433
3,092
3,092
4,429
4,429
4,945
4,945
3,375
3,375
3,915
3,915
5,776
5,776
4,684
4,684
5,504
5,504
6,060
6,060
6,589
6,589
8,731
8,731
8,671
12,035
12,035
7,260
7,260
8,646
8,646
7,312
7,312
7,296
7,296
3,131
3,131
3,052
3,052
3,290
3,290
3,122
3,122
1,190
1,190
1,033
1,033
820
820
854
854
2,104
2,104
3,590
3,590
2,020
2,020
2,473
2,473
3,482
3,482
5,259
5,259
0
9,184
11,363
11,363
9,613
10,676
10,6769,61311,36311,3639,18405,2595,2593,4823,4822,4732,4732,0202,0203,5903,5902,1042,1048548548208201,0331,0331,1901,1903,1223,1223,2903,2903,0523,0523,1313,1317,2967,2967,3127,3128,6468,6467,2607,26012,03512,0358,6718,7318,7316,5896,5896,0606,0605,5045,5044,6844,6845,7765,7763,9153,9153,3753,3754,9454,9454,4294,4293,0923,0922,4332,4333,3273,3273,1023,1023,8213,8214,4364,4364,2734,2734,1814,1813,0173,0172,5692,56910,72710,7279,9999,99910,27910,27912,99912,99911,96611,9667,5757,5756,5996,5995,5485,5484,9624,9623,9323,9325,7335,7335,7335,7332,4742,4741,9001,9002,4882,4882,6152,6151,3851,3852,5352,5352,4472,4471,6671,6672,1622,1621,9351,9352,2052,2052,1872,1872,6632,6632,8562,8566,9116,9116,6806,6807,2167,2166,7726,7725,8805,8804,8355,7365,7365,6745,6745,2995,2995,0915,0914,5964,5964,8874,8877,7637,7634,1564,1564,6324,6321,7041,7044,1264,1261,4649349348188181,3501,3501,2721,2491,2491,1221,1221,2391,2391,4959039031,2451,2451,1811,1811,5001,5002,1002,1002,2002,2001,7001,7001,1001,1009009001,0001,0008008008008001,4001,4009009001,0001,0001,1001,1001,1001,1001,6001,6001,4001,4001,4008,3008,300000000
   > Total Current Liabilities 
0
0
0
0
0
0
8,300
8,300
1,300
1,300
1,300
1,400
1,400
1,100
1,100
1,100
1,100
1,000
1,000
1,000
1,000
1,400
1,400
800
800
800
800
1,000
1,000
900
900
1,100
1,100
1,700
1,700
2,200
2,200
2,100
2,100
1,500
1,500
1,181
1,181
1,245
1,245
903
903
1,495
1,239
1,239
1,122
1,122
1,249
1,249
1,272
1,350
1,350
818
818
934
934
1,464
2,826
2,826
1,704
1,704
2,063
2,063
1,607
1,607
4,681
4,681
2,832
2,832
3,638
3,638
4,786
4,786
5,118
5,118
5,674
5,674
5,736
5,736
1,618
2,356
2,356
6,772
6,772
7,216
7,216
6,680
6,680
6,911
6,911
2,856
2,856
2,663
2,663
2,187
2,187
2,205
2,205
1,935
1,935
2,162
2,162
1,667
1,667
2,447
2,447
2,535
2,535
1,385
1,385
2,615
2,615
2,458
2,458
1,879
1,879
2,362
2,362
2,832
2,832
2,832
2,832
1,949
1,949
3,603
3,603
5,069
5,069
5,982
5,982
7,358
7,358
9,790
9,790
12,649
12,649
10,028
10,028
9,858
9,858
10,630
10,630
2,532
2,532
2,988
2,988
4,161
4,161
4,257
4,257
4,436
4,436
3,821
3,821
3,102
3,102
3,327
3,327
2,433
2,433
3,092
3,092
4,429
4,429
2,431
2,431
2,435
2,435
2,636
2,636
2,743
2,743
2,200
2,200
2,707
2,707
2,650
2,650
2,077
2,077
4,962
4,962
5,292
2,087
2,087
1,747
1,747
4,191
4,191
1,127
1,127
703
703
833
833
795
795
1,102
1,102
970
970
876
876
767
767
673
673
766
766
1,368
1,368
2,895
2,895
1,361
1,361
1,837
1,837
2,885
2,885
4,716
4,716
0
8,652
9,876
9,876
8,842
10,100
10,1008,8429,8769,8768,65204,7164,7162,8852,8851,8371,8371,3611,3612,8952,8951,3681,3687667666736737677678768769709701,1021,1027957958338337037031,1271,1274,1914,1911,7471,7472,0872,0875,2924,9624,9622,0772,0772,6502,6502,7072,7072,2002,2002,7432,7432,6362,6362,4352,4352,4312,4314,4294,4293,0923,0922,4332,4333,3273,3273,1023,1023,8213,8214,4364,4364,2574,2574,1614,1612,9882,9882,5322,53210,63010,6309,8589,85810,02810,02812,64912,6499,7909,7907,3587,3585,9825,9825,0695,0693,6033,6031,9491,9492,8322,8322,8322,8322,3622,3621,8791,8792,4582,4582,6152,6151,3851,3852,5352,5352,4472,4471,6671,6672,1622,1621,9351,9352,2052,2052,1872,1872,6632,6632,8562,8566,9116,9116,6806,6807,2167,2166,7726,7722,3562,3561,6185,7365,7365,6745,6745,1185,1184,7864,7863,6383,6382,8322,8324,6814,6811,6071,6072,0632,0631,7041,7042,8262,8261,4649349348188181,3501,3501,2721,2491,2491,1221,1221,2391,2391,4959039031,2451,2451,1811,1811,5001,5002,1002,1002,2002,2001,7001,7001,1001,1009009001,0001,0008008008008001,4001,4001,0001,0001,0001,0001,1001,1001,1001,1001,4001,4001,3001,3001,3008,3008,300000000
       Short-term Debt 
0
0
0
0
0
0
4,900
4,900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
570
570
570
0
349
349
349
0
670
670
670
1,130
1,130
1,899
1,899
3,248
3,248
4,034
4,034
4,652
4,652
4,941
4,941
0
0
3,640
3,640
3,640
3,756
3,756
3,871
3,871
3,987
3,987
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35
35
35
35
61
61
61
61
61
61
65
65
57
57
1,744
1,744
2,326
2,326
4,385
4,385
5,810
5,810
46
46
7,094
7,094
7,086
7,086
7,085
7,085
33
33
31
31
31
31
29
29
22
22
15
15
7
7
3
3
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
222
222
222
195
195
3,584
3,584
3,607
237
237
248
248
2,538
2,538
252
252
252
252
253
253
268
268
277
277
283
283
52
52
36
36
37
37
60
60
154
154
171
171
178
178
178
178
206
206
207
207
0
223
1,863
1,863
2,588
2,825
2,8252,5881,8631,863223020720720620617817817817817117115415460603737363652522832832772772682682532532522522522522,5382,5382482482372373,6073,5843,5841951952222222220000000000000001133771515222229293131313133337,0857,0857,0867,0867,0947,09446465,8105,8104,3854,3852,3262,3261,7441,744575765656161616161613535353500000000000000000000003,9873,9873,8713,8713,7563,7563,6403,6403,640004,9414,9414,6524,6524,0344,0343,2483,2481,8991,8991,1301,13067067067003493493490570570570000000000000000000000000000000000000000000000000000004,9004,900000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36
0
0
0
2,287
0
0
0
0
0
0
0
0
0
0
0
234
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,623
1,623
0
2,354
2,593
2,5932,35401,6231,62300000000000000000000000234000000000002,287000360000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
1,100
1,100
800
800
800
800
800
600
600
600
600
600
600
600
600
900
900
500
500
600
600
800
800
700
700
800
800
1,400
1,400
1,900
1,900
1,800
1,800
1,100
1,100
1,027
1,027
1,084
1,084
718
718
1,341
1,085
1,085
919
919
1,063
1,063
979
1,165
1,165
625
625
703
703
786
1,588
1,588
1,404
1,404
857
857
488
488
424
424
598
598
699
699
526
526
485
485
414
414
476
476
995
1,715
1,715
1,783
1,783
2,288
2,288
1,548
1,548
1,594
1,594
1,733
1,733
1,781
1,781
1,118
1,118
952
952
897
897
1,214
1,214
791
791
979
979
672
672
742
742
1,294
1,294
1,808
1,808
1,335
1,335
1,729
1,729
1,328
1,328
1,328
1,328
1,117
1,117
1,576
1,576
1,681
1,681
2,456
2,456
1,805
1,805
2,344
2,344
2,157
2,157
1,665
1,665
967
967
1,723
1,723
1,271
1,271
1,217
1,217
1,471
1,471
2,447
2,447
2,081
2,081
2,317
2,317
1,598
1,598
1,506
1,506
1,213
1,213
1,395
1,395
1,391
1,391
1,011
1,011
887
887
927
927
972
972
460
460
741
741
850
850
689
689
791
791
680
768
768
672
672
620
620
472
472
165
165
255
255
205
205
383
383
189
189
451
451
369
369
198
198
378
378
712
712
957
957
377
377
963
963
2,151
2,151
2,788
2,788
0
6,443
6,567
6,567
5,455
6,264
6,2645,4556,5676,5676,44302,7882,7882,1512,1519639633773779579577127123783781981983693694514511891893833832052052552551651654724726206206726727687686807917916896898508507417414604609729729279278878871,0111,0111,3911,3911,3951,3951,2131,2131,5061,5061,5981,5982,3172,3172,0812,0812,4472,4471,4711,4711,2171,2171,2711,2711,7231,7239679671,6651,6652,1572,1572,3442,3441,8051,8052,4562,4561,6811,6811,5761,5761,1171,1171,3281,3281,3281,3281,7291,7291,3351,3351,8081,8081,2941,2947427426726729799797917911,2141,2148978979529521,1181,1181,7811,7811,7331,7331,5941,5941,5481,5482,2882,2881,7831,7831,7151,7159954764764144144854855265266996995985984244244884888578571,4041,4041,5881,5887867037036256251,1651,1659791,0631,0639199191,0851,0851,3417187181,0841,0841,0271,0271,1001,1001,8001,8001,9001,9001,4001,4008008007007008008006006005005009009006006006006006006006006008008008008008001,1001,100000000
       Other Current Liabilities 
0
0
0
0
0
0
2,300
2,300
500
500
500
600
600
500
500
500
500
400
400
400
400
500
500
300
300
200
200
200
200
200
200
300
300
300
300
300
300
300
300
400
400
155
155
161
161
185
185
154
154
154
203
203
186
186
293
185
185
193
193
231
231
678
668
668
300
300
857
857
1,119
1,119
3,090
3,090
607
607
543
543
1,012
1,012
599
599
608
608
319
319
623
641
641
1,349
1,349
1,172
1,172
1,261
1,261
1,330
1,330
1,123
1,123
882
882
1,069
1,069
1,253
1,253
1,038
1,038
948
948
876
876
1,468
1,468
1,863
1,863
643
643
1,321
1,321
615
615
509
509
572
572
1,443
1,443
1,443
1,443
767
767
1,156
1,156
1,644
1,644
1,200
1,200
1,168
1,168
1,636
1,636
7,051
7,051
1,269
1,269
1,805
1,805
1,822
1,822
1,228
1,228
1,740
1,740
2,659
2,659
1,781
1,781
2,333
2,333
1,489
1,489
26
26
1,818
1,818
1,219
1,219
1,697
1,697
3,038
3,038
1,420
1,420
1,548
1,548
1,709
1,709
1,771
1,771
1,740
1,740
1,966
1,966
1,578
1,578
1,193
1,193
587
587
199
1,082
1,082
205
205
210
210
214
214
217
217
221
221
226
226
230
230
234
234
373
373
362
362
438
438
328
328
502
502
1,767
1,767
806
806
696
696
528
528
1,721
1,721
0
1,986
1,446
1,446
799
1,011
1,0117991,4461,4461,98601,7211,7215285286966968068061,7671,7675025023283284384383623623733732342342302302262262212212172172142142102102052051,0821,0821995875871,1931,1931,5781,5781,9661,9661,7401,7401,7711,7711,7091,7091,5481,5481,4201,4203,0383,0381,6971,6971,2191,2191,8181,81826261,4891,4892,3332,3331,7811,7812,6592,6591,7401,7401,2281,2281,8221,8221,8051,8051,2691,2697,0517,0511,6361,6361,1681,1681,2001,2001,6441,6441,1561,1567677671,4431,4431,4431,4435725725095096156151,3211,3216436431,8631,8631,4681,4688768769489481,0381,0381,2531,2531,0691,0698828821,1231,1231,3301,3301,2611,2611,1721,1721,3491,3496416416233193196086085995991,0121,0125435436076073,0903,0901,1191,1198578573003006686686782312311931931851852931861862032031541541541851851611611551554004003003003003003003003003002002002002002002003003005005004004004004005005005005006006005005005002,3002,300000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
100
100
100
200
200
0
0
0
0
0
0
-100
-100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-32
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,300
1,300
1,300
0
2,569
2,569
2,569
2,549
2,549
3,082
3,082
2,055
2,055
958
958
305
305
181
181
0
0
0
3,217
3,217
3,524
3,524
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,684
0
30
30
21
21
112
112
2,901
2,901
2,901
2,901
1,983
1,983
1,359
1,359
479
479
617
617
217
217
2,176
2,176
350
350
251
251
141
141
97
97
37
37
29
29
20
20
16
16
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,514
2,514
940
940
1,279
1,279
3,033
3,033
2,484
2,484
2,797
2,797
3,410
3,410
4,512
4,512
3,769
3,769
3,379
9,948
9,948
5,513
5,513
4,455
4,455
6,185
6,185
6,593
6,593
2,298
2,298
2,257
2,257
2,188
2,188
2,152
2,152
314
314
266
266
147
147
88
88
736
736
695
695
659
659
636
636
597
597
543
543
0
532
1,487
1,487
771
576
5767711,4871,487532054354359759763663665965969569573673688881471472662663143142,1522,1522,1882,1882,2572,2572,2982,2986,5936,5936,1856,1854,4554,4555,5135,5139,9489,9483,3793,7693,7694,5124,5123,4103,4102,7972,7972,4842,4843,0333,0331,2791,2799409402,5142,51400000000000000161620202929373797971411412512513503502,1762,1762172176176174794791,3591,3591,9831,9832,9012,9012,9012,9011121122121303003,68400000000000000000000000000003,5243,5243,2173,2170001811813053059589582,0552,0553,0823,0822,5492,5492,5692,5692,56901,3001,3001,300000000000000000000000-32000000000000000000-100-10000000020020010010010000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,631
0
4,466
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,369
0
2,318
5,949
0
4,496
0
4,251
0
6,014
0
6,248
0
1,993
0
1,934
0
1,876
0
1,816
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000001,81601,87601,93401,99306,24806,01404,25104,49605,9492,31802,369000000000000000000000000000000000000000000000000000004,46604,63100000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,198
0
1,198
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000001,19801,19800000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30
0
46
46
0
92
0
100
0
119
0
143
0
370
0
370
0
225
0
258
0
258
0
258
0
258
0
254
0
254
0
228
0
228
0
40
0
40
0
40
0
40
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,400
0
1,061
3,895
0
874
0
82
0
57
0
239
0
207
0
177
0
180
0
217
0
209
0
158
0
35
0
4
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000001040350158020902170180017702070239057082087403,8951,06101,4000000000000000000000000000000000000000000000000000000000000000400400400400228022802540254025802580258025802250370037001430119010009204646030000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
95
0
95
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000009509500000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
0
0
0
4,400
4,400
3,700
3,700
3,700
2,400
2,400
7,200
7,200
5,900
5,900
4,700
4,700
3,600
3,600
2,100
2,100
10,700
10,700
9,400
9,400
8,100
8,100
16,100
16,100
15,200
15,200
12,200
12,200
10,200
10,200
9,000
9,000
12,700
12,700
14,881
14,881
14,032
14,032
12,640
12,640
11,572
9,347
9,347
8,205
8,205
6,863
6,863
10,763
9,359
9,359
6,748
6,748
4,983
4,983
3,630
4,603
4,603
6,939
6,939
7,360
7,360
9,248
9,248
9,290
9,290
14,046
14,046
22,711
22,711
20,081
20,081
17,275
17,275
14,734
14,734
13,730
13,730
19,837
27,171
27,171
23,873
23,873
21,480
21,480
24,751
24,751
27,424
27,424
26,721
26,721
23,294
23,294
20,955
20,955
18,160
18,160
15,562
15,562
12,781
12,781
11,544
11,544
9,945
9,945
45,908
45,908
66,309
66,309
62,379
62,379
58,396
58,396
55,687
55,687
53,402
53,402
45,947
45,947
45,947
45,947
43,672
43,672
40,573
40,573
37,965
37,965
36,134
36,134
33,535
33,535
36,612
36,612
44,700
44,700
41,380
41,380
36,144
36,144
32,151
32,151
29,298
29,298
31,993
31,993
29,368
29,368
26,365
26,365
25,004
25,004
26,970
26,970
26,764
26,764
23,170
23,170
20,371
20,371
18,408
18,408
17,489
17,489
16,631
16,631
15,498
15,498
12,948
12,948
10,332
10,332
10,041
10,041
8,703
8,703
10,200
10,200
9,096
9,096
6,439
6,439
5,174
3,930
3,930
6,548
6,548
13,844
13,844
12,907
12,907
35,111
35,111
46,992
46,992
61,112
61,112
61,294
61,294
70,967
70,967
65,532
65,532
62,047
62,047
56,879
56,879
53,301
53,301
48,780
48,780
42,695
42,695
38,468
38,468
34,989
34,989
30,135
30,135
22,602
22,602
0
10,234
4,826
4,826
6,102
2,912
2,9126,1024,8264,82610,234022,60222,60230,13530,13534,98934,98938,46838,46842,69542,69548,78048,78053,30153,30156,87956,87962,04762,04765,53265,53270,96770,96761,29461,29461,11261,11246,99246,99235,11135,11112,90712,90713,84413,8446,5486,5483,9303,9305,1746,4396,4399,0969,09610,20010,2008,7038,70310,04110,04110,33210,33212,94812,94815,49815,49816,63116,63117,48917,48918,40818,40820,37120,37123,17023,17026,76426,76426,97026,97025,00425,00426,36526,36529,36829,36831,99331,99329,29829,29832,15132,15136,14436,14441,38041,38044,70044,70036,61236,61233,53533,53536,13436,13437,96537,96540,57340,57343,67243,67245,94745,94745,94745,94753,40253,40255,68755,68758,39658,39662,37962,37966,30966,30945,90845,9089,9459,94511,54411,54412,78112,78115,56215,56218,16018,16020,95520,95523,29423,29426,72126,72127,42427,42424,75124,75121,48021,48023,87323,87327,17127,17119,83713,73013,73014,73414,73417,27517,27520,08120,08122,71122,71114,04614,0469,2909,2909,2489,2487,3607,3606,9396,9394,6034,6033,6304,9834,9836,7486,7489,3599,35910,7636,8636,8638,2058,2059,3479,34711,57212,64012,64014,03214,03214,88114,88112,70012,7009,0009,00010,20010,20012,20012,20015,20015,20016,10016,1008,1008,1009,4009,40010,70010,7002,1002,1003,6003,6004,7004,7005,9005,9007,2007,2002,4002,4003,7003,7003,7004,4004,400000000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,595
30
30
30
30
30
30
30
30
30
31
31
31
31
33
33
33
33
33
33
33
33
33
33
36
36
38
38
39
39
42
42
44
44
49
49
50
50
50
50
51
51
52
52
56
61
61
62
62
63
63
67
67
71
71
73
73
73
73
74
74
74
74
74
74
75
75
79
79
82
82
120
120
132
132
133
133
133
133
135
135
135
135
135
135
135
135
135
135
135
135
136
136
136
136
136
136
148
148
166
166
167
167
167
167
167
167
168
168
183
183
189
189
194
194
204
204
226
226
245
245
248
248
247
247
247
247
249
249
24
24
24
24
26
26
29
29
31
31
33
33
39
39
47
47
48
48
49
63
63
2
2
6
6
10
10
28
28
34
34
41
41
42
42
48
48
48
48
48
48
48
48
48
48
48
48
48
48
48
48
48
48
48
48
48
48
0
49
50
50
57
59
5957505049048484848484848484848484848484848484848484848424241413434282810106622636349484847473939333331312929262624242424249249247247247247248248245245226226204204194194189189183183168168167167167167167167166166148148136136136136136136135135135135135135135135135135135135133133133133132132120120828279797575747474747474737373737171676763636262616156525251515050505049494444424239393838363633333333333333333333313131313030303030303030301,5950000000000000000000000000000000000000000
   Retained Earnings Total Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,610
0
3,756
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000003,75603,61000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
-600
-600
-600
-600
-600
-600
-600
-600
-600
-600
-600
-600
-600
-600
-600
-600
-600
-600
-600
-600
-600
-700
-700
-700
-700
-700
-700
-600
-600
-300
-300
-155
-155
-832
-832
7
7
34
58
58
38
38
16
16
17
9
9
17
17
17
17
35
-690
-690
-690
-690
-690
-690
-770
-770
-770
-770
-770
-770
-770
-770
-10
-10
-177
-177
-95
-95
-234
-234
-171
49
49
79
79
24
24
46
46
265
265
316
316
378
378
-7
-7
17
17
-1,455
-1,455
-1,455
-1,455
0
-1,797
0
0
0
0
0
-2,149
-2,149
-2,149
-20
-20
-2
-2
717
717
-974
-974
-974
-974
-338
-338
-867
-867
-389
-389
52
52
266
266
428
428
-43
-43
-7
-7
-1,088
-1,088
-91
-91
-114
-114
-93
-93
54
54
-114
-114
-160
-160
-49
-49
-186
-186
-401
-401
-97
-97
50
50
87
87
71
71
-5
-5
6
6
18
18
29
29
11
11
-1
-1
-9
-9
0
-7,613
-3
-3
-7,810
1
1
1
1
-8,545
-8,545
-4
-4
63
63
-12
-12
-47
-47
-208
-208
-247
-247
-250
-250
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-690
-690
0
0
-689
-689
0
0
00-689-68900-690-69000000000000000-250-250-247-247-208-208-47-47-12-126363-4-4-8,545-8,5451111-7,810-3-3-7,6130-9-9-1-111112929181866-5-5717187875050-97-97-401-401-186-186-49-49-160-160-114-1145454-93-93-114-114-91-91-1,088-1,088-7-7-43-434284282662665252-389-389-867-867-338-338-974-974-974-974717717-2-2-20-20-2,149-2,149-2,14900000-1,7970-1,455-1,455-1,455-1,4551717-7-73783783163162652654646242479794949-171-234-234-95-95-177-177-10-10-770-770-770-770-770-770-770-770-690-690-690-690-690-690351717171799171616383858583477-832-832-155-155-300-300-600-600-700-700-700-700-700-700-600-600-600-600-600-600-600-600-600-600-600-600-600-600-600-600-600-600-600-600-6000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,331
0
6,372
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
323,357
0
323,701
323,289
0
329,294
0
339,972
0
340,228
0
366,235
0
381,427
0
398,925
0
402,541
0
415,955
0
416,435
0
416,779
0
417,217
0
417,459
0
417,791
0
418,091
0
418,270
0
418,456
0
418,513
0
0
0
0
0
0
0
0
0
0
0000000000418,5130418,4560418,2700418,0910417,7910417,4590417,2170416,7790416,4350415,9550402,5410398,9250381,4270366,2350340,2280339,9720329,2940323,289323,7010323,357000000000000000000000000000000000000000000000000000006,37206,33100000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-3,1630-696-6960-6960-6960-6960-6960-6960-6960-6960-6960-6960-6960-696-6630-7170-6210-621-6210-6210-6210-621-6150-5760-6710-6350000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
47,900
47,900
47,900
47,900
47,900
48,200
48,200
54,700
54,700
54,700
54,700
55,900
55,900
56,000
56,000
56,000
56,000
65,700
65,700
65,900
65,900
66,200
66,200
75,900
75,900
77,600
77,600
77,500
77,500
78,100
78,100
78,600
78,600
83,900
83,900
87,896
88,540
89,784
89,784
89,618
90,491
95,009
94,305
95,264
95,525
95,563
96,350
97,267
103,407
102,454
103,491
102,469
104,460
102,595
104,586
102,635
105,951
105,951
111,972
111,972
117,814
117,814
123,822
123,822
131,904
131,904
142,613
142,613
158,279
158,279
158,024
158,024
158,440
158,440
159,632
159,632
161,653
161,653
169,629
180,633
180,633
182,384
182,384
183,852
183,852
191,689
191,689
199,239
199,239
202,408
202,408
204,637
204,637
206,078
206,078
206,424
206,424
208,100
208,100
208,733
208,733
208,874
208,874
210,359
210,359
250,154
250,154
272,978
272,978
275,242
275,242
273,174
273,174
274,121
274,121
274,371
274,371
264,511
264,511
264,511
264,511
264,760
264,760
264,930
264,930
264,958
264,958
264,994
264,994
265,181
265,181
274,671
274,671
288,671
288,671
288,925
288,925
289,053
289,053
289,199
289,199
289,563
289,563
296,058
296,058
298,236
298,236
299,598
299,598
302,729
302,729
308,007
308,007
312,764
312,764
313,185
313,185
313,220
313,220
313,274
313,274
313,619
313,619
315,864
315,864
315,980
315,980
316,238
316,238
316,307
316,307
316,748
316,748
317,419
317,419
321,635
321,635
322,946
322,946
323,357
323,357
323,701
323,289
323,289
329,294
329,294
339,972
339,972
348,773
348,773
366,235
366,235
381,427
381,427
398,925
398,925
402,541
402,541
415,955
415,955
416,435
416,435
416,779
416,779
417,217
417,217
417,459
417,459
417,791
417,791
418,091
418,091
418,270
418,270
418,456
418,456
418,513
418,513
419,486
419,486
0
419,004
419,412
420,101
423,206
423,714
423,714423,206420,101419,412419,0040419,486419,486418,513418,513418,456418,456418,270418,270418,091418,091417,791417,791417,459417,459417,217417,217416,779416,779416,435416,435415,955415,955402,541402,541398,925398,925381,427381,427366,235366,235348,773348,773339,972339,972329,294329,294323,289323,289323,701323,357323,357322,946322,946321,635321,635317,419317,419316,748316,748316,307316,307316,238316,238315,980315,980315,864315,864313,619313,619313,274313,274313,220313,220313,185313,185312,764312,764308,007308,007302,729302,729299,598299,598298,236298,236296,058296,058289,563289,563289,199289,199289,053289,053288,925288,925288,671288,671274,671274,671265,181265,181264,994264,994264,958264,958264,930264,930264,760264,760264,511264,511264,511264,511274,371274,371274,121274,121273,174273,174275,242275,242272,978272,978250,154250,154210,359210,359208,874208,874208,733208,733208,100208,100206,424206,424206,078206,078204,637204,637202,408202,408199,239199,239191,689191,689183,852183,852182,384182,384180,633180,633169,629161,653161,653159,632159,632158,440158,440158,024158,024158,279158,279142,613142,613131,904131,904123,822123,822117,814117,814111,972111,972105,951105,951102,635104,586102,595104,460102,469103,491102,454103,40797,26796,35095,56395,52595,26494,30595,00990,49189,61889,78489,78488,54087,89683,90083,90078,60078,60078,10078,10077,50077,50077,60077,60075,90075,90066,20066,20065,90065,90065,70065,70056,00056,00056,00056,00055,90055,90054,70054,70054,70054,70048,20048,20047,90047,90047,90047,90047,900000000



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue202
Cost of Revenue-42
Gross Profit160160
 
Operating Income (+$)
Gross Profit160
Operating Expense-32,076
Operating Income-31,916-31,916
 
Operating Expense (+$)
Research Development10,939
Selling General Administrative21,137
Selling And Marketing Expenses623
Operating Expense32,07632,699
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-31,916
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-28,962-34,870
EBIT - interestExpense = -31,916
-28,962
-28,962
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-31,916-28,962
Earnings Before Interest and Taxes (EBITDA)-31,678
 
After tax Income (+$)
Income Before Tax-28,962
Tax Provision-0
Net Income From Continuing Ops0-28,962
Net Income-28,962
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses32,118
Total Other Income/Expenses Net2,9540
 

Technical Analysis of AIM ImmunoTech Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of AIM ImmunoTech Inc. The general trend of AIM ImmunoTech Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine AIM ImmunoTech Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of AIM ImmunoTech Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.197 < 0.235 < 0.2401.

The bearish price targets are: 0.1628.

Tweet this
AIM ImmunoTech Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of AIM ImmunoTech Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

AIM ImmunoTech Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of AIM ImmunoTech Inc. The current macd is -0.0099245.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the AIM ImmunoTech Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for AIM ImmunoTech Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the AIM ImmunoTech Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
AIM ImmunoTech Inc Daily Moving Average Convergence/Divergence (MACD) ChartAIM ImmunoTech Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of AIM ImmunoTech Inc. The current adx is 13.68.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell AIM ImmunoTech Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
AIM ImmunoTech Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of AIM ImmunoTech Inc. The current sar is 0.244.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
AIM ImmunoTech Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of AIM ImmunoTech Inc. The current rsi is 35.50. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
AIM ImmunoTech Inc Daily Relative Strength Index (RSI) ChartAIM ImmunoTech Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of AIM ImmunoTech Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the AIM ImmunoTech Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
AIM ImmunoTech Inc Daily Stochastic Oscillator ChartAIM ImmunoTech Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of AIM ImmunoTech Inc. The current cci is -204.9169609.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
AIM ImmunoTech Inc Daily Commodity Channel Index (CCI) ChartAIM ImmunoTech Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of AIM ImmunoTech Inc. The current cmo is -37.90437341.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
AIM ImmunoTech Inc Daily Chande Momentum Oscillator (CMO) ChartAIM ImmunoTech Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of AIM ImmunoTech Inc. The current willr is -90.36144578.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
AIM ImmunoTech Inc Daily Williams %R ChartAIM ImmunoTech Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of AIM ImmunoTech Inc.

AIM ImmunoTech Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of AIM ImmunoTech Inc. The current atr is 0.02179727.

AIM ImmunoTech Inc Daily Average True Range (ATR) ChartAIM ImmunoTech Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of AIM ImmunoTech Inc. The current obv is 3,695,480.

AIM ImmunoTech Inc Daily On-Balance Volume (OBV) ChartAIM ImmunoTech Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of AIM ImmunoTech Inc. The current mfi is 42.97.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
AIM ImmunoTech Inc Daily Money Flow Index (MFI) ChartAIM ImmunoTech Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for AIM ImmunoTech Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-13MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-08-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-16MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-09-25STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-11BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-11-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

AIM ImmunoTech Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of AIM ImmunoTech Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.497
Ma 20Greater thanMa 500.211
Ma 50Greater thanMa 1000.233
Ma 100Greater thanMa 2000.269
OpenGreater thanClose0.189
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of AIM ImmunoTech Inc with someone you think should read this too:
  • Are you bullish or bearish on AIM ImmunoTech Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about AIM ImmunoTech Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about AIM ImmunoTech Inc

I send you an email if I find something interesting about AIM ImmunoTech Inc.


Comments

How you think about this?

Leave a comment

Stay informed about AIM ImmunoTech Inc.

Receive notifications about AIM ImmunoTech Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.